Kisspeptin-10 Protocol Guide: Dosage & Reconstitution
Kisspeptin-10
Kisspeptin-10 is a peptide studied for its role in regulating the hypothalamic–pituitary–gonadal (HPG) axis. It stimulates natural hormone signaling by promoting the release of GnRH, which influences LH, FSH, and downstream testosterone or estrogen production.
How It Works
Kisspeptin → GnRH ↑ → LH/FSH ↑ → Natural Hormone Production ↑
Kisspeptin-10 acts upstream in the hormonal cascade by stimulating gonadotropin-releasing hormone (GnRH). This leads to increased luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which support natural endocrine function and reproductive signaling.
Acts upstream of the HPG axis (not direct hormone replacement)
Stimulates natural GnRH release from the hypothalamus
Triggers LH and FSH production from the pituitary
Can influence downstream testosterone or estrogen production through HPG-axis signaling
Kisspeptin Research Protocol Ranges
Research context
The fixed microgram ranges below reflect community-discussed research frameworks rather than a standardized clinical Kisspeptin-10 protocol. Human studies have used several different dosing methods, including weight-based IV and SubQ administration, bolus dosing, and controlled infusions.
The fixed microgram ranges below reflect community-discussed research frameworks rather than a standardized clinical Kisspeptin-10 protocol. Human studies have used several different dosing methods, including weight-based IV and SubQ administration, bolus dosing, and controlled infusions.
Standard Setup
Vial10 mg
Water3.0 mL bacteriostatic water
Concentration3.33 mg/mL
Conversion1 unit = 33.3 mcg
Standard Range
Dose100–300 mcg
Units3–9 units
Volume0.03–0.09 mL
Advanced Range
Dose300–500 mcg
Units9–15 units
Volume0.09–0.15 mL
Frequency1x daily or every other day
TimingMorning or pre-event
RouteSubcutaneous
Cycle Length4–8 weeks
Community protocols often use consistent daily timing, while clinical research has used scheduled bolus (a single dose given at one time) doses or controlled infusions.
Kisspeptin Research Protocol
10 mg vial → 3.0 mL BAC Water → 1 unit = 33.3 mcg
Weeks 1–2
Start / Sensitivity Phase
Dose100 mcg
Units3 units
Volume0.03 mL
Weeks 3–8
Build / Active Phase
Dose200 mcg
Units6 units
Volume0.06 mL
Optional Higher Range
Advanced Range
Dose300–500 mcg
Units9–15 units
Volume0.09–0.15 mL
Simple structure
Start lower to assess response, then build into a stable range. Higher doses are typically situational and not always necessary.
Start lower to assess response, then build into a stable range. Higher doses are typically situational and not always necessary.
When & How to Use
Reproductive hormone signaling research
HPG-axis and GnRH/LH/FSH research
Fertility and reproductive-function research
Community discussions involving libido and hormone support
Research into restoring or stimulating reproductive signaling in certain forms of hormone dysfunction
Reconstitution & Dosing (10 mg Vial)
Vial10 mg
Water3.0 mL
Concentration3.33 mg/mL
Conversion1 unit = 33.3 mcg
Dose Reference
3 units ≈ 100 mcg
6 units ≈ 200 mcg
9 units ≈ 300 mcg
12 units ≈ 400 mcg
15 units ≈ 500 mcg
Reconstitution Steps
Draw 3.0 mL bacteriostatic water
Inject slowly into vial
Gently swirl (do not shake)
Allow full dissolution
Storage
Refrigerate at 2–8°C after reconstitution
Do not freeze after mixing
Use within 30 days
Storage & Shelf Life
Storage & Shelf Life
Lyophilized (Unmixed)
Refrigerated (2–8°C): ~12–24 months
Frozen (−20°C): up to ~2–3 years
Reconstituted (Mixed)
Refrigerated (2–8°C): ~30 days
Do not freeze after mixing
Avoid repeated temperature changes
Best Practice
Keep refrigerated, protect from light, and discard if the solution becomes cloudy, discolored, or develops particles.
Keep refrigerated, protect from light, and discard if the solution becomes cloudy, discolored, or develops particles.
Research Cycle Length & Timing Between Cycles
Active Cycle → Hormone Signaling Support → Break → Reassess
Standard Research Cycle
Cycle Length4–8 weeks
FrequencyDaily or every other day
Research Time Between Cycles
Break2–4 weeks off
GoalReassess hormone response
Simple Strategy
Kisspeptin is often used in shorter cycles to stimulate natural signaling. Time off helps evaluate whether endogenous hormone production is improving.
Kisspeptin is often used in shorter cycles to stimulate natural signaling. Time off helps evaluate whether endogenous hormone production is improving.
Why administration pattern matters
Kisspeptin signaling may respond differently to continuous versus intermittent exposure. Human research has found that repeated intermittent Kisspeptin-10 administration can maintain gonadotropin signaling, while continuous exposure may produce a different response over time. There is not currently an established clinical rule requiring a specific number of weeks on or off.
Kisspeptin signaling may respond differently to continuous versus intermittent exposure. Human research has found that repeated intermittent Kisspeptin-10 administration can maintain gonadotropin signaling, while continuous exposure may produce a different response over time. There is not currently an established clinical rule requiring a specific number of weeks on or off.
What Human Research Has Studied
Human Research
Kisspeptin-10 has been administered to healthy men and women in controlled human studies.
Human studies show that Kisspeptin-10 can stimulate LH and FSH release through the reproductive hormone pathway.
In men, Kisspeptin-10 has also increased testosterone under certain experimental conditions.
Both IV and subcutaneous administration have been investigated.
Newer research has also examined repeated SubQ administration rather than only single-dose exposure.
Important distinction
Kisspeptin-10 has legitimate human research behind it, but researchers have used controlled, study-specific dosing methods. This does not establish the fixed-dose community protocols commonly discussed online as standard clinical treatment.
Kisspeptin-10 has legitimate human research behind it, but researchers have used controlled, study-specific dosing methods. This does not establish the fixed-dose community protocols commonly discussed online as standard clinical treatment.
Men and women may respond differently
Kisspeptin response is strongly influenced by reproductive physiology. Human research has found clear LH and FSH responses in men, while responses in women can vary depending on menstrual-cycle phase. This is one reason Kisspeptin-10 should not be viewed as a simple “hormone booster” with the same effect in everyone.
Kisspeptin response is strongly influenced by reproductive physiology. Human research has found clear LH and FSH responses in men, while responses in women can vary depending on menstrual-cycle phase. This is one reason Kisspeptin-10 should not be viewed as a simple “hormone booster” with the same effect in everyone.
Monitoring During Use
LH and FSH response
Testosterone in men when relevant
Estradiol and reproductive hormone patterns in women when relevant
Menstrual-cycle timing and response in women
Libido and reproductive-function changes
Any unexpected hormonal symptoms
Research Findings & Potential Benefits
Stimulates natural reproductive hormone signaling
Human studies demonstrate increases in LH and FSH under certain conditions
Can influence downstream testosterone production in men
Being studied for fertility and reproductive endocrine applications
Commonly discussed for libido and hormone-support research
Potential Side Effects
Flushing or warmth
Headache
Temporary fatigue
Hormonal fluctuations
Important Notes
Acts upstream (natural signaling vs direct hormone replacement)
Best used in cycles
Response varies based on baseline hormone levels
Monitor for hormonal changes
Important Disclaimer
Kisspeptin-10 is an investigational peptide and not FDA-approved. This content is for educational and research purposes only.
Research & References
Primary Research
- Seminara SB, Messager S, Chatzidaki EE, et al. The GPR54 Gene as a Regulator of Puberty. New England Journal of Medicine. 2003.
- Dhillo WS, Chaudhri OB, Patterson M, et al. Kisspeptin-54 Stimulates the Hypothalamic-Pituitary Gonadal Axis in Human Males. Journal of Clinical Endocrinology & Metabolism. 2005.
- George JT, Veldhuis JD, Roseweir AK, et al. Kisspeptin-10 Is a Potent Stimulator of LH and Increases Pulse Frequency in Men. Journal of Clinical Endocrinology & Metabolism. 2011.
- Jayasena CN, Abbara A, Narayanaswamy S, Comninos AN, et al. Direct Comparison of the Effects of Intravenous Kisspeptin-10, Kisspeptin-54 and GnRH on Gonadotrophin Secretion in Healthy Men. Human Reproduction. 2015.
Reviews & Supporting Research
Research Note: The clinical trials above establish Kisspeptin-10's role in stimulating the hypothalamic-pituitary-gonadal axis in confirmed human clinical settings. Self-administration dosing protocols described on this page extrapolate from this clinical research and compounding-community practice rather than from validated consumer dosing trials.
Comments
Post a Comment